Insights Into Integer (ITGR) Q4: Wall Street Projections for Key Metrics

Wall Street analysts forecast that Integer (ITGR) will report quarterly earnings of $1.46 per share in its upcoming release, pointing to a year-over-year increase of 5%. It is anticipated that revenues will amount to $446.16 million, exhibiting an increase of 8% compared to the year-ago quarter.The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.With that in mind, let's delve into the average projections of some Integer metrics that are commonly tracked and projected by analysts on Wall Street.Based on the collective assessment of analysts, 'Sales- Medical Sales- Cardiac Rhythm Management & Neuromodulation' should arrive at $166.61 million. The estimate indicates a change of +9% from the prior-year quarter.Analysts predict that the 'Sales- Medical Sales- Advanced Surgical, Orthopedics & Portable Medical' will reach $24.95 million. The estimate indicates a change of -12.8% from the prior-year quarter.According to the collective judgment of analysts, 'Sales- Medical Sales- Cardio & Vascular' should come in at $254.59 million. The estimate points to a change of +14.4% from the year-ago quarter.View all Key Company Metrics for Integer here>>>Shares of Integer have experienced no change in the past month compared to the +4.7% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), ITGR is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Just Released: Zacks Top 10 Stocks for 2025Hurry – you can still get in early on our 10 top tickers for 2025. Handpicked by Zacks Director of Research Sheraz Mian, this portfolio has been stunningly and consistently successful. From inception in 2012 through November, 2024, the Zacks Top 10 Stocks gained +2,112.6%, more than QUADRUPLING the S&P 500’s +475.6%. Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2025. You can still be among the first to see these just-released stocks with enormous potential. See New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Integer Holdings Corporation (ITGR): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks